Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Hiroshi Yotsuyanagi and Hiroyuki Nagai.
Hiroshi Yotsuyanagi
Connection Strength
0.575
Hiroyuki Nagai
  1. Association of coagulopathy with liver dysfunction in patients with COVID-19. Hepatol Res. 2021 Feb; 51(2):227-232.
    View in: PubMed
    Score: 0.228
  2. Characterization of a new SARS-CoV-2 variant that emerged in Brazil. Proc Natl Acad Sci U S A. 2021 07 06; 118(27).
    View in: PubMed
    Score: 0.060
  3. Association of HLA-DRB1*09:01 with severe COVID-19. HLA. 2021 07; 98(1):37-42.
    View in: PubMed
    Score: 0.059
  4. Antibody titers against SARS-CoV-2 decline, but do not disappear for several months. EClinicalMedicine. 2021 Feb; 32:100734.
    View in: PubMed
    Score: 0.058
  5. Comparison of Rapid Antigen Tests for COVID-19. Viruses. 2020 12 10; 12(12).
    View in: PubMed
    Score: 0.057
  6. Antibody response to SARS-CoV-2 in people living with HIV. J Microbiol Immunol Infect. 2021 Feb; 54(1):144-146.
    View in: PubMed
    Score: 0.057
  7. Seroconversion against SARS-CoV-2 occurred after the recovery in patients with COVID-19. J Med Virol. 2021 02; 93(2):692-694.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.